|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-15
|
$1,428,925
|
$85,736
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-05
|
$303,240
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-03
|
$626,868
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
WDR5 as a Critical Co-Factor for MYC
|
5F31CA210429-03
|
$29,196
|
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Variant identification for cancer genomics
|
1R15CA220059-01A1
|
$447,460
|
|
GRIGORIEV, ANDREY
|
RUTGERS THE STATE UNIV OF NJ CAMDEN
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-03
|
$39,076
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-04
|
$3,698,322
|
$776,648
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-04
|
$603,232
|
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-04
|
$493,498
|
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
5K07CA211971-02
|
$170,636
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
University of Michigan Surgical Oncology Research Training Program
|
5T32CA009672-28
|
$192,856
|
|
ZOU, WEIPING
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa Surgical Oncology Training Grant
|
5T32CA148062-08
|
$420,203
|
|
WEIGEL, RONALD
|
UNIVERSITY OF IOWA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
5P30CA023074-38
|
$3,533,423
|
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Understanding the Mechanism of a Gut Microbial Genotoxin Involved in Colorectal Carcinogenesis
|
5R01CA208834-03
|
$383,091
|
|
BALSKUS, EMILY
|
HARVARD UNIVERSITY
|
|
Underlying Mechanisms in Angiosarcoma
|
5R01CA197943-04
|
$352,275
|
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$925,596
|
$277,679
|
Gu, Shuo
|
CCR (NCI)
|
|
UCSD Cancer Center Training Program in Drug Development
|
5T32CA121938-13
|
$569,911
|
|
BOUVET, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
UCLA Tumor Immunology Training Program
|
3T32CA009120-39S1
|
$39,503
|
$7,901
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UCLA Tumor Immunology Training Program
|
5T32CA009120-39
|
$441,837
|
$88,367
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor subtypes and therapy response in pancreatic cancer
|
5R01CA199064-03
|
$591,406
|
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Treatment of Castration-resistant Prostate Cancer (CRPC)
|
5R01CA196835-03
|
$354,563
|
|
LIU, XIAOQI
|
PURDUE UNIVERSITY
|
|
Treatment decision making in low-risk thyroid cancer
|
5R01CA201198-03
|
$518,509
|
|
HAYMART, MEGAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-02
|
$2,184,998
|
$131,100
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Pediatric Cancer Epidemiology Research Training Grant
|
5T32CA099936-14
|
$258,342
|
|
SPECTOR, LOGAN
|
UNIVERSITY OF MINNESOTA
|
|
Translational Approaches to Melanoma Prevention in Children at High Genetic Risk
|
5K07CA196985-04
|
$136,555
|
|
WU, YELENA
|
UNIVERSITY OF UTAH
|
|
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
|
1R01CA218004-01A1
|
$597,598
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer
|
5F30CA203095-03
|
$49,524
|
|
PRIEDIGKEIT, NOLAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Transcriptional Regulation of Lung Cancer Identity
|
5R01CA212415-02
|
$336,379
|
|
SNYDER, ERIC
|
UNIVERSITY OF UTAH
|
|
Transcriptional Mechanisms Governing Telomerase Activity
|
5F30CA221285-02
|
$49,524
|
|
PENEV, ALEX
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training Program in Cancer-related Population Sciences
|
5T32CA094061-17
|
$289,734
|
|
NEUGUT, ALFRED
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-13
|
$467,856
|
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
2T32CA009515-31
|
$563,174
|
$563,174
|
PRESS, OLIVER
|
UNIVERSITY OF WASHINGTON
|
|
Training Grant in Molecular Imaging Research
|
5T32CA079443-18
|
$479,597
|
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Grant in Cancer Biology
|
5T32CA186892-03
|
$219,528
|
|
HUNG, MIEN-CHIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
TP53 Germline Mutations: Beyond LFS
|
1R01CA219556-01A1
|
$377,037
|
|
LI, YONG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Topical delivery of non-?-blocking R-carvedilol for prevention of UV-induced skin cancer
|
1R15CA227946-01
|
$409,223
|
|
HUANG, YING
|
WESTERN UNIVERSITY OF HEALTH SCIENCES
|
|
Tissue-specific tumor suppressor effects of p53
|
1R01CA200256-01
|
$400,089
|
$200,045
|
MANFREDI, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Tissue-specific tumor suppressor effects of p53
|
5R01CA200256-04
|
$409,185
|
$204,593
|
MANFREDI, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
|
5R01CA207237-03
|
$395,166
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
1R35CA197725-01
|
$709,490
|
$354,745
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
|
Therapeutic targeting of Kras-driven Lung Adenocarcinoma
|
5R01CA206367-03
|
$357,994
|
|
FIELDS, ALAN
|
MAYO CLINIC JACKSONVILLE
|
|
Therapeutic strategies for targeting PARP1 in small cell lung cancer
|
5R01CA207295-03
|
$366,000
|
|
BYERS, LAUREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
$108,199
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Gene Therapy for this search: $40,320,999
|